Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis

American Journal of Reproductive Immunology

Volumn 61, Issue 4, 2009, Pages 286-293

  Cho, Si Hyun ^a   Ahn, Young Sun ^b   Choi, Young Sik ^c   Seo, Seok Kyo ^a   Nam, Anna ^a   Kim, Hye Yeon ^c   Kim, Jae Hoon ^a   Park, Ki Hyun ^c   Cho, Dong Jae ^c   Lee, Byung Seok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Department of Obstetrics and Gynecology   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Endometriosis; Endometrium; mRNA; Osteopontin, plasma

Indexed keywords

MESSENGER RNA; OSTEOPONTIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OSTEOPONTIN; RNA, MESSENGER; ROC CURVE;

EID: 62249094458     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00692.x     Document Type: Article

References (31)

1. Cramer DW, Missmer SA: The epidemiology of endometriosis. Ann NY Acad Sci 2002; 955: 11-22. Discussion 34-16, 396-406.
2. Crosignani P, Olive D, Bergqvist A, Luciano A: Advances in the management of endometriosis: An update for clinicians. Hum Reprod Update 2006; 12: 179-189.
3. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-469.
4. Berkkanoglu M, Arici A: Immunology and endometriosis. Am J Reprod Immunol 2003; 50: 48-59.
5. D'Hooghe TM, Kyama C, Debrock S, Meuleman C, Mwenda JM: Future directions in endometriosis research. Ann NY Acad Sci 2004; 1034: 316-325.
6. Reinholt FP, Hultenby K, Oldberg A, Heinegard D: Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 1990; 87: 4473-4475.
7. Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR: Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Mol Biol Cell 1992; 3: 1169-1180.
8. Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mansson H: The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1087-1097.
9. Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW: A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 1995; 270: 26232-26238.
10. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995; 95: 713-724.
11. Apparao KB, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR, Lessey BA: Osteopontin and its receptor alpha v beta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 2001; 86: 4991-5000.
12. Lessey BA: Implantation defects in infertile women with endometriosis. Ann NY Acad Sci 2002; 955: 265-280. Discussion 293-265, 396-406.
13. Odagiri K, Konno R, Fujiwara H, Netsu S, Ohwada M, Shibahara H, Suzuki M: Immunohistochemical study of osteopontin and L-selectin in a rat endometriosis model and in human endometriosis. Fertil Steril 2007; 88: 1207-1211.
14. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817-821.
15. Meden H, Fattahi-Meibodi A: CA 125 in benign gynecological conditions. Int J Biol Markers 1998; 13: 231-237.
16. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, Bossuyt PM: The performance of CA-125 measurement in the detection of endometriosis: A meta-analysis. Fertil Steril 1998; 70: 1101-1108.
17. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
18. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
19. ScatenaAM, Liaw L, Giachelli CM: Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309.
20. Crawford HC, Matrisian LM, Liaw L: Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res 1998; 58: 5206-5215.
21. Konno R, Fujiwara H, Netsu S, Odagiri K, Shimane M, Nomura H, Suzuki M: Gene expression profiling of the rat endometriosis model. Am J Reprod Immunol 2007; 58: 330-343.
22. Ulukus M, Cakmak H, Arici A: The role of endometrium in endometriosis. J Soc Gynecol Investig 2006; 13: 467-476.
23. Wei Q, St Clair JB, Fu T, Stratton P, Nieman LK: Reduced expression of biomarkers associated with the implantation window in women with endometriosis. Fertil Steril 2008. [Epub ahead of print].
24. Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sorensen ES: Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scand J Immunol 2007; 65: 453-460.
25. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW: Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001; 7: 4060-4066.
26. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC: Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 2002; 287: 1671-1679.
27. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F: Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170: 333-337.
28. Wong CK, Lit LC, Tam LS, Li EK, Lam CW: Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44: 602-606.
29. Bautista DS, Saad Z, Chambers AF, Tonkin KS, O'Malley FP, Singhal H, Tokmakejian S, Bramwell V, Harris JF: Quantification of osteopontin in human plasma with an ELISA: Basal levels in pre- and postmenopausal women. Clin Biochem 1996; 29: 231-239.
30. Spaczynski RZ, Duleba AJ: Diagnosis of endometriosis. Semin Reprod Med 2003; 21: 193-208.
31. Cho H, Hong SW, Oh YJ, Kim MA, Kang ES, Lee JM, Kim SW, Kim SH, Kim JH, Kim YT, Lee K: Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol 2008; 134: 909-917.